Chiriva Internati Maurizio 4
4 · Kiromic Biopharma, Inc. · Filed Sep 10, 2021
Insider Transaction Report
Form 4
Chiriva Internati Maurizio
DirectorChairman, CEO, and President
Transactions
- Purchase
Common Stock
2021-09-09$3.70/sh+2,800$10,357→ 1,378,072 total